首页> 外国专利> ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID COMBINED WITH MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DIEASES

ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID COMBINED WITH MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DIEASES

机译:适应性改良病毒载体可提供核糖体核糖核酸与信使核糖核酸的组合,作为治疗糖尿病和其他蛋白质缺乏症的医学治疗设备

摘要

Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses and virus-like vehicles to act as a transport mechanism to deliver ribosomal RNA molecules along with messenger RNA molecules to target cells in the body. Delivering to the Beta cells in the body the ribosomal RNA needed to assist ribosomes with the construction of insulin or insulin receptors along with messenger RNA will lead to enhanced production of biologically active insulin or insulin receptors by Beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors the result of which will help properly regulate blood glucose levels throughout the body utilizing innate regulatory mechanisms.
机译:糖尿病是血糖升高的疾病,通常与胰岛素产生或胰岛素受体产生的缺乏直接相关。本文所述的创新治疗策略利用修饰的病毒和类似病毒的媒介物作为转运机制,将核糖体RNA分子与信使RNA分子一起输送至体内靶细胞。将核糖体协助使核糖体构建胰岛素或胰岛素受体以及信使RNA,将核糖体RNA传递至体内的β-核糖体RNA将导致β细胞在必要时增强生物活性胰岛素或胰岛素受体的产生,这将导致纠正胰岛素或胰岛素受体的缺乏,其结果将有助于利用先天的调节机制适当地调节全身的血糖水平。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号